Application of Beta Regression to Analyze Ischemic Stroke Volume in NINDS rt-PA Clinical Trials
- 1 September 2011
- journal article
- research article
- Published by S. Karger AG in Neuroepidemiology
- Vol. 37 (2) , 73-82
Abstract
Background and Purpose: Ischemic stroke lesion volumes have proven difficult to analyze due to the extremely skewed shape of their underlying distribution. We introduce an extension of generalized linear models, beta regression, as a possible method of modeling extremely skewed distributions as evidenced in ischemic stroke lesion volumes. Methods: The NINDS rt-PA clinical trials measured ischemic stroke lesion volume as a secondary trial outcome. Three-month lesion volumes from these trials were analyzed using beta regression. A multi-variable regression model associating explanatory variables with ischemic stroke lesion volumes was constructed using accepted model building strategies and compared with the previously published volumetric analysis. Results: Beta regression produced a similar model when compared to the previous analysis published by the study group. All previously identified variables of importance were detected in the model building process. The age by treatment interaction described in previous studies was also found in this analysis, confirming the strong effect age has on stroke outcomes. Further, a treatment effect was elicited in terms of odds ratios, yielding a previously unknown quantification of the effect of rt-PA on lesion volumes. Conclusions: Beta regression proved adept in modeling ischemic stroke lesions and offered the interpretation of covariates in terms of odds ratios. Beta regression is seen as a legitimate alternative to analyze ischemic stroke volumes.Keywords
This publication has 26 references indexed in Scilit:
- Predictive Value of Ischemic Lesion Volume Assessed With Magnetic Resonance Imaging for Neurological Deficits and Functional Outcome Poststroke: A Critical Review of the LiteratureNeurorehabilitation and Neural Repair, 2006
- Proof-of-Principle Phase II MRI Studies in StrokeStroke, 2006
- Effect of Intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed TomographyStroke, 2000
- Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome?Stroke, 2000
- Generalized Efficacy of t-PA for Acute StrokeStroke, 1997
- Measurement of Infarct Size Using MRI Predicts Prognosis in Middle Cerebral Artery InfarctionStroke, 1995
- A rapid, reliable, and valid method for measuring infarct and brain compartment volumes from computed tomographic scans.Stroke, 1994
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Measurements of acute cerebral infarction: a clinical examination scale.Stroke, 1989
- Estimating the Dimension of a ModelThe Annals of Statistics, 1978